Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03249818 · ClinicalTrials.gov registry record · NA
HITT Device Pilot Testing for Traumatic Brain Injury
A NA study, sponsored by Rebiscan.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT03249818: Completed NA study, sponsored by Rebiscan.
NCT03249818 is a NA study that has completed, run by Rebiscan. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03249818, a NA study, has completed, sponsored by Rebiscan.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The purpose of this research study is to collect data from the eyes of traumatic brain injury (TBI) patients. Patients will look at a green target that will measure the fixation of the eye for 30 seconds. In that 30 seconds, the location of the green target will change and the participant is to track, with their eyes, the light as best they can. The device will measure how well fixation was maintained and the speed of the saccadic movements of the eye. Data will then be used to determine whether there is correlation between these measures and known TBI.
Primary Outcome
Patients who have diagnosed TBI and are admitted to the hospital for treatment will have their eyes scanned to identify whether the HITT device can accurately identify patients with TBI
Interventions
- DEVICE HITT device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2017-08-22 |
| Est. Completion | 2018-02-28 |
| Phase | NA |
What the finished NCT03249818 record still lists
NCT03249818 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which HITT device is the first listed.
NCT03249818 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03249818 about?
NCT03249818 is a clinical study titled "HITT Device Pilot Testing for Traumatic Brain Injury". The purpose of this research study is to collect data from the eyes of traumatic brain injury (TBI) patients. Patients will look at a green target that will measure the fixation of the eye for 30 seconds. In that 30 seconds, the location of the green target will change and the participant is to trac...
What is the current status of trial NCT03249818?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2017-08-22. Estimated completion is 2018-02-28.
What interventions are being tested in trial NCT03249818?
The interventions under investigation include: HITT device (DEVICE).
Who is sponsoring clinical trial NCT03249818?
This trial is sponsored by Rebiscan, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03249818's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI